Wellmark Int'l dba Central Life Science was issued Stop Sale, Use, or Removal Order for violation to FIFRA Section 12 (a)(1)(E) which prohibits product being sold for failure to meet export labeling requirements in 40 CFR 168.65. Release of Stop Sale issued on 10/5/15.